Robotic Spot Spraying of Harrisia Cactus (Harrisia martinii) in Grazing Pastures of the Australian Rangelands.

Harrisia cactus, Harrisia martinii, is a serious weed affecting hundreds of thousands of hectares of native pasture in the Australian rangelands. Despite the landmark success of past biological control agents for the invasive weed and significant investment in its eradication by the Queensland Government (roughly $156M since 1960), it still takes hold in the cooler rangeland environments of northern New South Wales and southern Queensland. In the past decade, landholders with large infestations in these locations have spent approximately $20,000 to $30,000 per annum on herbicide control measures to reduce the impact of the weed on their grazing operations. Current chemical control requires manual hand spot spraying with high quantities of herbicide for foliar application. These methods are labour intensive and costly, and in some cases inhibit landholders from performing control at all. Robotic spot spraying offers a potential solution to these issues, but existing solutions are not suitable for the rangeland environment. This work presents the methods and results of an in situ field trial of a novel robotic spot spraying solution, AutoWeed, for treating harrisia cactus that (1) more than halves the operation time, (2) can reduce herbicide usage by up to 54% and (3) can reduce the cost of herbicide by up to $18.15 per ha compared to the existing hand spraying approach. The AutoWeed spot spraying system used the MobileNetV2 deep learning architecture to perform real time spot spraying of harrisia cactus with 97.2% average recall accuracy and weed knockdown efficacy of up to 96%. Experimental trials showed that the AutoWeed spot sprayer achieved the same level of knockdown of harrisia cactus as traditional hand spraying in low, medium and high density infestations. This work represents a significant step forward for spot spraying of weeds in the Australian rangelands that will reduce labour and herbicide costs for landholders as the technology sees more uptake in the future.

DeepWeeds: A Multiclass Weed Species Image Dataset for Deep Learning.

Robotic weed control has seen increased research of late with its potential for boosting productivity in agriculture. Majority of works focus on developing robotics for croplands, ignoring the weed management problems facing rangeland stock farmers. Perhaps the greatest obstacle to widespread uptake of robotic weed control is the robust classification of weed species in their natural environment. The unparalleled successes of deep learning make it an ideal candidate for recognising various weed species in the complex rangeland environment. This work contributes the first large, public, multiclass image dataset of weed species from the Australian rangelands; allowing for the development of robust classification methods to make robotic weed control viable. The DeepWeeds dataset consists of 17,509 labelled images of eight nationally significant weed species native to eight locations across northern Australia. This paper presents a baseline for classification performance on the dataset using the benchmark deep learning models, Inception-v3 and ResNet-50. These models achieved an average classification accuracy of 95.1% and 95.7%, respectively. We also demonstrate real time performance of the ResNet-50 architecture, with an average inference time of 53.4 ms per image. These strong results bode well for future field implementation of robotic weed control methods in the Australian rangelands.

Intravenous multipotent adult progenitor cell therapy attenuates activated microglial/macrophage response and improves spatial learning after traumatic brain injury.

We previously demonstrated that the intravenous delivery of multipotent adult progenitor cells (MAPCs) after traumatic brain injury (TBI) in rodents provides neuroprotection by preserving the blood-brain barrier and systemically attenuating inflammation in the acute time frame following cell treatment; however, the long-term behavioral and anti-inflammatory effects of MAPC administration after TBI have yet to be explored. We hypothesized that the intravenous injection of MAPCs after TBI attenuates the inflammatory response (as measured by microglial morphology) and improves performance at motor tasks and spatial learning (Morris water maze [MWM]). MAPCs were administered intravenously 2 and 24 hours after a cortical contusion injury (CCI). We tested four groups at 120 days after TBI: sham (uninjured), injured but not treated (CCI), and injured and treated with one of two concentrations of MAPCs, either 2 million cells per kilogram (CCI-2) or 10 million cells per kilogram (CCI-10). CCI-10 rats showed significant improvement in left hind limb deficit on the balance beam. On the fifth day of MWM trials, CCI-10 animals showed a significant decrease in both latency to platform and distance traveled compared with CCI. Probe trials revealed a significant decrease in proximity measure in CCI-10 compared with CCI, suggesting improved memory retrieval. Neuroinflammation was quantified by enumerating activated microglia in the ipsilateral hippocampus. We observed a significant decrease in the number of activated microglia in the dentate gyrus in CCI-10 compared with CCI. Our results demonstrate that intravenous MAPC treatment after TBI in a rodent model offers long-term improvements in spatial learning as well as attenuation of neuroinflammation.

Superior mesenteric artery pseudoaneurysm after blunt abdominal trauma.

True aneurysms and pseudoaneurysms of the visceral arteries are uncommon. Visceral artery aneurysms (VAAs) represent 0.1-0.2% of all vascular aneurysms and were also found in 0.1% of autopsies. VAAs most commonly affect the splenic (60%), hepatic (20%), and superior mesenteric (9%) arteries. Mesenteric injury caused by blunt abdominal trauma is relatively rare. A 30-year-old man arrived at our trauma hospital and was found to have a traumatic pseudoaneurysm of the superior mesenteric artery (SMA) after a motor vehicle collision. To date, only 10 visceral arterial pseudoaneurysms have been reported in the literature. We present an 11th case of a pseudoaneurysm involving the SMA after blunt abdominal trauma.

Idiopathic gastric perforation in an asplenic infant.

INTRODUCTION: The cause of idiopathic gastric perforations in neonates remains unknown. Perforations of the abdominal oesophagus, stomach and duodenum in infants and children are the rarest type of intestinal perforations. There are 21 reported cases of an idiopathic gastric rupture in non-neonates. CASE REPORT: A 6-week-old boy presented with nausea, vomiting and decreased oral intake. Physical examination revealed a firm, distended abdomen tender. Abdominal lateral decubitus radiograph revealed massive free air. Patient was found to have an idiopathic gastric perforation of the greater curvature with incidental findings of asplenia. CONCLUSION: Paediatric abdominal foregut perforations have diverse aetiologies. The foregut is the least likely portion of the gastrointestinal tract to perforate in children. The aetiology is unknown but there are many postulated theories. We present a case of an idiopathic gastric rupture involving the greater curvature of 6-week-old boy with incidental findings of being asplenic.

Progenitor cells: therapeutic targets after traumatic brain injury.

Traumatic brain injuries and their associated treatments carry high cost in both financial impact and morbidity to human life. Recent studies and trials present promising results in reducing secondary injury in the days and weeks following the primary insult. A number of studies, both pre-clinical and clinical, have found that different populations of stem/progenitor cells result in a reduction of inflammation, maintenance of the blood brain barrier, and an overall improved prognosis. The mechanism of action of these cellular therapies appears to rely upon the ability of the cells to influence microglia/macrophage phenotype and alter the state of the inflammatory response. The spleen has become an area of intense interest as an arena where therapeutic cells interact with reactive macrophages to cause system-level changes in immune activity. Additionally, the spleen enacts anti-inflammatory responses originating in the CNS, delivered through vagal activity with a recently described mechanism culminating in acetylcholine release. This review provides a summary of recent findings as to the mechanisms of action observed in current cellular therapies.

Solitary splenic metastasis from ovarian carcinosarcoma: a case report.

INTRODUCTION: Metastatic tumors to the spleen are rare but are usually found in conjunction with metastasis to other organs. The most common sources of splenic metastasis are breast, lung and colorectal cancers as well as melanoma and ovarian carcinoma. A solitary carcinosarcoma metastasis to the spleen of any origin is very rare. To the best of our knowledge, there are fewer than 30 reported cases of ovarian primary tumors with solitary metastasis to the spleen, and only three solitary primary carcinosarcomas to the spleen have been reported, of which one is female. We present what is, to the best of our knowledge, the first case of a solitary metastatic carcinosarcoma to the spleen arising from a primary ovarian carcinsarcoma. CASE PRESENTATION: A 72-year-old Hispanic woman status post-total abdominal hysterectomy for ovarian carcinosarcoma presented with complaints of early satiety and abdominal pain for the past two months with a 30-lb unintentional weight loss. An initial computed tomographic scan of her abdomen and pelvis revealed a 30 cm × 27 cm splenic mass with displacement of the left kidney, stomach and liver. The patient was found to have a solitary metastatic carcinosarcoma of the spleen with biphasic epithelial (carcinomatous) and mesenchymal (sarcomatous) elements consistent with carcinosarcoma. CONCLUSION: Carcinosarcoma of the spleen is a rare tumor. Carcinosarcomas are a biphasic neoplasm comprising malignant epithelial and mesenchymal components arising from a stem cell capable of differentiation. They can arise anywhere in the female genital tract, most commonly from the endometrium. Even though it is rare, carcinosarcomas can metastasize to the spleen. This unique case of a solitary splenic metastasis from ovarian carcinosarcoma has particular interest in medicine, especially for the specialties of surgical oncology, pathology and hematology/oncology.